Neuromodulation of the median nerve in carpal tunnel syndrome, a single-blind, randomized controlled study

CONCLUSIONS: : NiPRF effectively improves symptoms and functionality in patients with CTS for up to 3 months. Thus, NiPRF can be considered an easy, safe, and useful alternative treatment modality for CTS.PMID:38061772 | DOI:10.3344/kjp.23232

Source: Korean Journal of Pain - December 7, 2023 Category: Anesthesiology Authors: Gevher Rabia Gen ç Perdecioğlu Mehlika Panpall ı Ateş Damla Y ürük Ömer Taylan Akkaya Source Type: research